You are here

Senesco

Senesco Announces Reverse Stock Split

Yahoo/BusinessWire

Sat, 10/19/13 - 03:48 pm

Senesco’s Lead Therapeutic Candidate, SNS01-T, Granted Orphan Drug Status from FDA for Treatment of Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Yahoo

Mon, 07/30/12 - 11:06 am

mantle cell lymphoma

diffuse large B-cell lymphoma